Update of influenza vaccine strains in Europe. Quality issues

by A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev
Published 2018-02-01

General Considerations on Clinical Trials of Hemophilia Medicines

by Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. A. Merkulov
Published 2020-03-01

Authorisation of Non-Innovator Biotherapeutic (Biosimilar) Products in the USA

by A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. D. Mosyagin
Published 2019-03-01

General Characteristics of Adjuvants and Their Mechanism of Action (Part 1)

by N. A. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya, L. A. Gayderova
Published 2020-12-01

Immune Response Induced by Immunisation with Antiviral Vaccines

by N. A. Alpatova, Zh. I. Avdeeva, L. A. Gayderova, S. L. Lysikova, N. V. Medunitsyn
Published 2020-03-01

Orphan drugs and the principles of their marketing authorization procedures and clinical use

by A. A. Soldatov, Zh. I. Avdeeva, N. A. Alpatova, N. V. Medunitsyn, S. L. Lysikova
Published 2018-02-01

Factor VIII products: key aspects of development, clinical research and use (part 1)

by Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. D. Mosyagin, V. A. Merkulov
Published 2021-03-01

Factor VIII products: key aspects of development, clinical research and use (part 2)

by Zh. I. Avdeeva, A. A. Soldatov, V. P. Bondarev, V. D. Mosyagin, V. A. Merkulov
Published 2021-07-01

The safety of biological preparations. Part 2. Safety issues of biosimilars

by A. A. Soldatov, Zh. I. Avdeeva, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev
Published 2018-02-01

Safety of biological preparations. Report 1. Terminology and classification issues

by A. A. Soldatov, Zh. I. Avdeeva, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev
Published 2018-02-01

General characteristics of adjuvants and their mechanisms of action (part 2)

by N. А. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya, L. A. Gayderova, V. P. Bondarev
Published 2021-03-01

Pharmacokinetic properties of the preparations of protein origin

by A. A. Soldatov, Zh. I. Avdeeva, N. A. Alpatova, N. V. Medunitsyn, S. L. Lysikova, V. A. Merkulov
Published 2018-02-01

Assessment of biotechnological products specific activity

by N. A. Alpatova, L. A. Gayderova, A. K. Yakovlev, E. V. Motuzova, S. L. Lysikova, A. A. Soldatov, Zh. I. Avdeeva
Published 2018-02-01

Modern biological/biotechnological medicinal products. Topical issues and prospects for development

by Yu. V. Olefir, N. V. Medunitsyn, Zh. I. Avdeeva, A. A. Soldatov, A. A. Movsesyants, V. A. Merkulov, V. P. Bondarev
Published 2018-02-01

Russian and International Regulatory Recommendations for the Development and Marketing Authorisation of COVID-19 Vaccines in the Context of the Pandemic

by A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. A. Merkulov, V. D. Mosyagin, V. B. Ivanov, D. V. Gorenkov, L. M. Khantimirova
Published 2020-12-01

Preparations of next generation monoclonal antibodies (issues and prospects)

by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, N. V. Medunitsyn, V. P. Bondarev, A. N. Mironov, V. A. Merkulov, I. V. Sakaeva
Published 2018-02-01

First available biosimilar monoclonal antibodies

by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, V. P. Bondarev, Yu. V. Olefir, V. A. Merkulov, V. D. Mosyagin, N. V. Medunitsyn
Published 2018-02-01

Recombinant granulocyte colony stimulating factor biosimilars. Quality assessment

by Zh. I. Avdeeva, A. A. Soldatov, N. A. Alpatova, M. V. Kiselevsky, S. L. Lysikova, V. P. Bondarev, N. V. Medunitsyn, V. D. Mosyagin, V. A. Merkulov, A. N. Mironov
Published 2018-02-01

Vaccines with adjuvants. Preclinical studies

by Zh. I. Avdeeva, N. A. Alpatova, V. P. Bondarev, R. A. Volkova, N. I. Lonskaya, E. V. Lebedinskaya, N. V. Medunitsyn, A. N. Mironov, N. A. Ozeretskovsky, A. A. Soldatov, V. A. Shevtsov
Published 2018-02-01